Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial.
Oriol MitjàMarc Corbacho-MonnéMaria UbalsCristian TebéJudith PeñafielAurelio TobiasEster BallanaAndrea AlemanyNúria Riera-MartíCarla A PérezClara SuñerPep LaportePol AdmellaJordi MitjàMireia CluaLaia BertranMaria SarquellaSergi GavilánJordi AraJosep M ArgimonJordi CasabonaGabriel CuatrecasasPaz CañadasAleix Elizalde-TorrentRobert FabregatMagí FarréAnna ForcadaGemma Flores-MateoEsteve MuntadaNúria NadalSilvia NarejosAroa NietoNuria PratJordi PuigCarles QuiñonesJuliana Reyes-UreñaFerran Ramírez-ViaplanaLidia RuizEva Riveira-MuñozAlba SierraCésar VelascoRosa Maria Vivanco-HidalgoAlexis SentísCamila G-BeirasBonaventura ClotetMartí Vall-MayansPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
In patients with mild COVID-19, no benefit was observed with HCQ beyond the usual care.